Charles Joussain - Concepedia

Author

Charles Joussain

Université de Versailles Saint-Quentin-en-Yvelines ORCID

Also Known As

C. Joussain, Charles Joussain

Publications

459

Citations

H-Index

Concepts

All Affiliations

Université de Versailles Saint-Quentin-en-Yvelines Hôpital Raymond-Poincaré Inserm Assistance Publique – Hôpitaux de Paris CHU Dijon Bourgogne

About

Charles Joussain is an author at Université de Versailles Saint-Quentin-en-Yvelines specializing in medicine, health sciences, and exercise.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	109
2	Health Sciences	3	3	75
3	Public Health	1	1	17
4	Applied Physiology	1	1	44
5	Cell Biology	1	1	27

Charles Joussain

Publications

292

Citations

H-Index

Page 1

	Year	Citations
Eccentric training in chronic heart failure: Feasibility and functional effects. Results of a comparative study D. Besson, Charles Joussain, Vincent Grémeaux, Annals of Physical and Rehabilitation Medicine Heart FailureChronic Heart FailureExerciseMedicineAerobic Exercise	2013	44
Long‐term outcomes and risks factors for failure of intradetrusor onabotulinumtoxin A injections for the treatment of refractory neurogenic detrusor overactivity Charles Joussain, Mélanie Popoff, V. Phé, Neurourology and Urodynamics	2017	43
Respiratory impairment in multiple sclerosis: a study of respiratory function in wheelchair‐bound patients Jonathan Lévy, Djamel Bensmaïl, Angélique Brotier-Chomienne, European Journal of Neurology	2017	31
Botulinum Neurotoxin Light Chains Expressed by Defective Herpes Simplex Virus Type-1 Vectors Cleave SNARE Proteins and Inhibit CGRP Release in Rat Sensory Neurons Charles Joussain, Olivier Le Coz, Andrey Pichugin, Toxins Inhibit Cgrp ReleaseSynaptic TransmissionImmunologyViral PathogenesisCytoskeleton	2019	27
Is It Possible to Individualize Intensity of Eccentric Cycling Exercise From Perceived Exertion on Concentric Test? Davy Laroche, Charles Joussain, Claire Espagnac, Archives of Physical Medicine and Rehabilitation	2012	26
Safety and Efficacy of Intracavernosal Injections of AbobotulinumtoxinA (Dysport®) as Add on Therapy to Phosphosdiesterase Type 5 Inhibitors or Prostaglandin E1 for Erectile Dysfunction—Case Studies François Giuliano, Charles Joussain, P. Denys Toxins Molecular PharmacologyIntracavernosal InjectionsUrologyErectile DysfunctionPain Medicine	2019	24
Barriers to physical activity in coronary artery disease patients: Development and validation of a new scale Charles Joussain, Jean-Michel Joubert, Davy Laroche, Annals of Physical and Rehabilitation Medicine New ScalePhysical ActivityKinesiologyHealth PolicyCardiovascular Disease	2017	17
Long Term Effectiveness and Safety of Intracavernosal Botulinum Toxin A as an Add-on Therapy to Phosphosdiesterase Type 5 Inhibitors or Prostaglandin E1 Injections for Erectile Dysfunction François Giuliano, Charles Joussain, P. Denys The Journal of Sexual Medicine	2021	17
Development and Validation of a Questionnaire to Assess Barriers to Physical Activity After Stroke: The Barriers to Physical Activity After Stroke Scale Joffrey Drigny, Charles Joussain, Vincent Grémeaux, Archives of Physical Medicine and Rehabilitation Stroke ScalePhysical ActivityPhysical Activity EpidemiologyAdapted Physical ActivityStroke Rehabilitation	2019	14
Outcomes of ileal conduit urinary diversion in patients with multiple sclerosis W. Akakpo, Emmanuel Chartier‐Kastler, Charles Joussain, Neurourology and Urodynamics	2020	13

Page 1